Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
04/2003
04/03/2003CA2461095A1 Process for making substituted pyrazoles
04/03/2003CA2461091A1 Use of hmgb1 for the activation of dendritic cells
04/03/2003CA2461089A1 Pharmaceutically acceptable salts of 20(s)-camptothecins
04/03/2003CA2460953A1 Proteins associated with cell growth, differentiation, and death
04/03/2003CA2459943A1 Androstanes as androgen receptor modulators
04/03/2003CA2458279A1 Modulation of vitamin storage
04/03/2003CA2455117A1 Enzyme phosphorylating ser46 of p53
04/03/2003CA2453985A1 Receptors and membrane-associated proteins
04/02/2003WO2002028821A2 Propionic acid derivatives with ppar-alpha activating properties
04/02/2003EP1298348A1 Bush, group of bush, suspension cross-member, vehicle, method for mounting a bush and method for mounting a group of bushes
04/02/2003EP1298211A2 Polynucleotide segment of HPV16 Genome
04/02/2003EP1298208A2 Ribozymes targeting a hiv tat sequence
04/02/2003EP1298206A1 Use of the Factor VII-activating protease for prevention and therapy of vaso-proliferative disorders
04/02/2003EP1298145A1 Dds compound and process for the preparation thereof
04/02/2003EP1298144A2 Murine monoclonal anti-idiotype antibody 3H1
04/02/2003EP1298137A1 Novel substance having physiological activity, process for producing the same, and use
04/02/2003EP1298125A1 Substituted benzimidazole compounds and their use for the treatment of cancer
04/02/2003EP1297846A1 Method and composition for reconforming multi-epitopic antigens to initiate an immune response
04/02/2003EP1297835A1 Benzo[b]pyrano[3,2-h]acridin-7-one derivatives, processes for their preparation and pharmaceutical compositions thereof
04/02/2003EP1297833A1 Indole carboxylic acids as thyroid receptor ligands
04/02/2003EP1297832A2 Composition and methods for treating psoriasis
04/02/2003EP1297831A2 Compositions and methods for epidermal chemexfoliation
04/02/2003EP1297180A2 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
04/02/2003EP1297167A1 Tumour-cell specific gene expression and its use in cancer therapy
04/02/2003EP1297161A2 Methods and means for regulation of gene expression
04/02/2003EP1297152A2 Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof
04/02/2003EP1297137A2 Gp286 nucleic acids and polypeptides
04/02/2003EP1297135A2 Pd-l2 molecules: novel pd-1 ligands and uses therefor
04/02/2003EP1297133A2 Gp354 nucleic acids and polypeptides
04/02/2003EP1297130A2 G-protein coupled receptors
04/02/2003EP1297129A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use
04/02/2003EP1297126A1 Nucleotide and amino acid sequences of a cellular inhibitor of the dna replication in the epstein-barr herpes virus
04/02/2003EP1297125A2 Compositions and methods for treating neoplastic disease using inhibitors of laminin5beta3
04/02/2003EP1297121A2 Purging of cells using viruses
04/02/2003EP1297118A1 Prostase protein vaccine comprising derivatised thiol residues and methods for producing said antigen
04/02/2003EP1297116A2 Method for isolating and purifying a protein and resulting protein
04/02/2003EP1297017A2 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations
04/02/2003EP1297014A2 Transporters and ion channels
04/02/2003EP1297013A2 Use of taci as an anti-tumor agent
04/02/2003EP1297012A2 Novel fibroblast growth factors and nucleic acids encoding same
04/02/2003EP1297011A1 The t-cell protein tzon7, peptides and antibodies derived therefrom and uses thereof
04/02/2003EP1297007A2 Mammalian protein phosphatases
04/02/2003EP1297002A2 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery
04/02/2003EP1297001A1 Amphipathic linear peptides and compositions containing same
04/02/2003EP1296989A2 Polycyclic xanthones as antibiotics
04/02/2003EP1296985A2 Heteropolycyclic inhibitors
04/02/2003EP1296984A1 Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer
04/02/2003EP1296978A2 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity
04/02/2003EP1296976A1 Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them
04/02/2003EP1296975A1 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
04/02/2003EP1296972A1 Arylmethylamine derivatives for use as tryptase inhibitors
04/02/2003EP1296971A2 2-fluorobenzenesulfonyl compounds for the treatment of inflammation
04/02/2003EP1296959A1 Methods and compositions utilizing quinazolinones
04/02/2003EP1296953A2 Methods and compounds for inhibiting mrp1
04/02/2003EP1296949A2 Piperidine amides as modulators of chemokine receptor activity
04/02/2003EP1296946A1 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof
04/02/2003EP1296943A1 Amino acid derivatives and their use as medicines
04/02/2003EP1296936A1 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones
04/02/2003EP1296931A2 Polyamine analogues as cytotoxic agents
04/02/2003EP1296929A2 Modified forms of pharmacologically active agents and uses therefor
04/02/2003EP1296722A2 Radiotherapy
04/02/2003EP1296720A2 Poliovirus replicons encoding therapeutic agents and uses thereof
04/02/2003EP1296714A2 Methods for enhancing antibody-induced cell lysis and treating cancer
04/02/2003EP1296711A2 Human papilloma virus treatment
04/02/2003EP1296709A1 Solubilised protein vaccines
04/02/2003EP1296702A1 Neuroprotective peptides
04/02/2003EP1296700A1 Anti-carcinogenic activity of hydroxylated chalcone compounds extracted from licorice root
04/02/2003EP1296699A1 Therapeutic agents - iii
04/02/2003EP1296698A1 Therapeutic agents - ii
04/02/2003EP1296697A1 Therapeutic agents - i
04/02/2003EP1296676A1 Use of indole-3-acetic acid derivatives in medicine
04/02/2003EP1296670A1 Therapeutic combinations of fatty acids
04/02/2003EP1296659A1 Pharmaceutical compositions of 2'-deoxy-2'-(fluoromethylene)cytidine
04/02/2003EP1296647A2 Polymeric micelle compositions
04/02/2003EP1296644A2 Systems and methods for treating a mucosal surface
04/02/2003EP1296552A2 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of erk-5
04/02/2003EP1246627A4 Polyanhydrides with biologically active degradation products
04/02/2003EP1212312B1 Novel derivatives of flavones, xanthones and coumarins
04/02/2003EP1135126A4 Myt1 kinase inhibitors
04/02/2003EP1114051B1 INHIBITORS OF p38
04/02/2003EP1045863B1 Detoxication of active pharmaceutical substances using cyclodextrine oligomers
04/02/2003EP1030842B1 Metalloproteinase inhibitors
04/02/2003EP0993304B1 Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxamic acid derivative
04/02/2003EP0991643B1 Novel aminooxyamide tricyclic inhibitors of farnesylprotein transferase
04/02/2003EP0986570B1 Gemcitabine derivatives
04/02/2003EP0986387B1 FARNESYL TRANSFERASE INHIBITORS IN COMBINATION WITH HMG CoA REDUCTASE INHIBITORS FOR THE TREATMENT OF CANCER
04/02/2003EP0966456B1 Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof
04/02/2003EP0954519B1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof
04/02/2003EP0951467B1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE
04/02/2003EP0917458B1 Lyophilized thioxanthenone antimumor agents
04/02/2003EP0874846B1 Purine derivatives and processes for their preparation
04/02/2003EP0873295B1 Dimer-selective rxr modulators and methods for their use
04/02/2003EP0865445B1 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties
04/02/2003EP0763049B1 Nucleoside monophosphate derivatives, a process for their production and their use as immunosuppressive drugs
04/02/2003EP0700444B1 Immunotoxins comprising gelonin and an antibody
04/02/2003EP0696326B1 Use of NDV in the manufacture of a medicament for treating cancer
04/02/2003EP0681574B1 C7 Taxane derivatives and pharmaceutical compositions containing them
04/02/2003EP0621865B1 Rapamycin derivative and its medicinal use
04/02/2003EP0566732B1 Adeno-associated virus-2 basal vectors
04/02/2003CN1408022A Recombinant adenoviruses for sodium/iodide symporter (NIS)
1 ... 1583 1584 1585 1586 1587 1588 1589 1590 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 ... 2211